Focused Investors LLC Johnson & Johnson Transaction History

Focused Investors LLC

$3.05 Billion
Q2 2024

A detailed history of Focused Investors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Focused Investors LLC holds 1,192,150 shares of JNJ stock, worth $192 Million. This represents 5.72% of its overall portfolio holdings.

Number of Shares

1,192,150

Previous 1,226,350 2.79%

Holding current value

$192 Million

Previous $194 Million 10.18%

% of portfolio

5.72%

Previous 6.15%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$144.38 - $157.78 $4.94 Million - $5.4 Million	-34,200 Reduced 2.79%	1,192,150 $174 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $11.9 Million - $12.4 Million	-76,450 Reduced 5.87%	1,226,350 $194 Million
Q4 2023 Jan 25, 2024	SELL	$145.6 - $158.88 $1.05 Million - $1.14 Million	-7,200 Reduced 0.55%	1,302,800 $204 Million
Q3 2023 Oct 19, 2023	SELL	$155.75 - $174.48 $3.43 Million - $3.84 Million	-22,000 Reduced 1.65%	1,310,000 $204 Million
Q2 2023 Jul 25, 2023	SELL	$154.35 - $166.11 $995,557 - $1.07 Million	-6,450 Reduced 0.48%	1,332,000 $220 Million
Q1 2023 Apr 26, 2023	SELL	$151.05 - $180.26 $9.49 Million - $11.3 Million	-62,800 Reduced 4.48%	1,338,450 $207 Million
Q4 2022 Jan 25, 2023	SELL	$160.2 - $179.79 $2.15 Million - $2.41 Million	-13,400 Reduced 0.95%	1,401,250 $248 Million
Q3 2022 Oct 14, 2022	SELL	$161.33 - $179.52 $3.48 Million - $3.87 Million	-21,550 Reduced 1.5%	1,414,650 $231 Million
Q2 2022 Aug 01, 2022	SELL	$168.19 - $186.01 $302,742 - $334,818	-1,800 Reduced 0.13%	1,436,200 $255 Million
Q1 2022 Apr 20, 2022	SELL	$158.14 - $179.59 $6.36 Million - $7.22 Million	-40,200 Reduced 2.72%	1,438,000 $255 Million
Q4 2021 Feb 07, 2022	BUY	$155.93 - $173.01 $15.2 Million - $16.9 Million	97,400 Added 7.05%	1,478,200 $253 Million
Q3 2021 Oct 27, 2021	SELL	$161.5 - $179.47 $8.19 Million - $9.1 Million	-50,700 Reduced 3.54%	1,380,800 $223 Million
Q2 2021 Aug 03, 2021	BUY	$159.48 - $171.07 $6.67 Million - $7.15 Million	41,800 Added 3.01%	1,431,500 $236 Million
Q1 2021 Apr 26, 2021	BUY	$153.07 - $170.48 $15.6 Million - $17.4 Million	102,000 Added 7.92%	1,389,700 $228 Million
Q4 2020 Jan 22, 2021	SELL	$137.11 - $157.38 $1.38 Million - $1.59 Million	-10,100 Reduced 0.78%	1,287,700 $203 Million
Q3 2020 Oct 21, 2020	SELL	$140.38 - $153.83 $4.89 Million - $5.35 Million	-34,800 Reduced 2.61%	1,297,800 $193 Million
Q2 2020 Jul 23, 2020	SELL	$128.81 - $155.51 $1.29 Million - $1.56 Million	-10,000 Reduced 0.74%	1,332,600 $187 Million
Q1 2020 Apr 23, 2020	BUY	$111.14 - $153.99 $17.3 Million - $23.9 Million	155,500 Added 13.1%	1,342,600 $176 Million
Q4 2019 Jan 23, 2020	BUY	$127.5 - $146.44 $8.95 Million - $10.3 Million	70,200 Added 6.29%	1,187,100 $173 Million
Q3 2019 Oct 21, 2019	SELL	$126.95 - $142.14 $647,445 - $724,913	-5,100 Reduced 0.45%	1,116,900 $145 Million
Q2 2019 Jul 16, 2019	BUY	$131.15 - $144.24 $1.14 Million - $1.25 Million	8,700 Added 0.78%	1,122,000 $156 Million
Q1 2019 Apr 16, 2019	SELL	$125.72 - $139.79 $4.5 Million - $5 Million	-35,800 Reduced 3.12%	1,113,300 $156 Million
Q4 2018 Jan 25, 2019	SELL	$122.84 - $147.84 $6.17 Million - $7.42 Million	-50,200 Reduced 4.19%	1,149,100 $148 Million
Q3 2018 Oct 19, 2018	SELL	$121.58 - $142.88 $851,060 - $1 Million	-7,000 Reduced 0.58%	1,199,300 $166 Million
Q2 2018 Jul 24, 2018	BUY	$119.4 - $131.76 $8.26 Million - $9.12 Million	69,200 Added 6.09%	1,206,300 $146 Million
Q1 2018 Apr 20, 2018	BUY	$125.1 - $148.14 $5.89 Million - $6.98 Million	47,100 Added 4.32%	1,137,100 $146 Million
Q4 2017 Jan 23, 2018	BUY	$131.22 - $143.62 $11.1 Million - $12.1 Million	84,400 Added 8.39%	1,090,000 $152 Million
Q3 2017 Oct 19, 2017	BUY	$129.47 - $135.38 $130 Million - $136 Million	1,005,600	1,005,600 $131 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $422B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Focused Investors LLC with notifications on news.

Account

Focused Investors LLC Johnson & Johnson Transaction History